From the Lab to the Clinic: ELS Issues in Cancer Stem Cell Research

TERM: April 2010-March 2015

FUNDER: Genome Canada (via the Cancer Stem Cell Consortium)

PROJECT LEADER: Professor Timothy Caulfield

FUNDS: $500,000

PROJECT SUMMARY:
From the Lab to the Clinic: ELS Issues in Cancer Stem Cell Research is a project key to a larger Cancer Stem Cell Consortium (CSCC) funded initiative that aims to identify, characterize and develop methods of destroying leukemia stem cells (LSC). This latter research project involves three key phases of the innovation process: the use of a large tissue bank (basic research), the engagement of industry partners (commercialization) and the development of valuable therapeutics (translation) for patients with intractable leukemia. The ELS initiative led by HeaLS Research Director Timothy Caulfield explores the ethical, legal, social and policy issues affiliated with each realm of research associated with the innovative process. Currently, Caulfield’s team is investigating ELS challenges that characterize tissue banking and the commercialization process, in addition to those associated with the marketing of therapies. This latter component is being done through the lens of medical tourism.